MPNRF Blog

FDA Issues Verbal Hold for Geron's Imetelstat Application

Geron has been given verbal notification from the U.S. Food and Drug Administration (FDA) that its application for imetelstat has been placed on full clinical hold, affecting all ongoing company-sponsored clinical trials. A full clinical hold is an order that the FDA issues to a trial sponsor to suspend an ongoing clinical trial or delay a proposed trial. [...]

CONTINUE READING

Crafting the MPN Environment

The World Orphan Drug Congress recently put out an independent study of the most researched rare diseases. We were shocked to see that the MPNs (MPDs on the list) ranked No. 10 of 25.  [...]

CONTINUE READING

Clinical Trials News for PV and ET Patients

Last week two companies reported news on their clinical trials for myeloproliferative neoplasms: [...]

CONTINUE READING

This September We're Putting Patients in the Driver's Seat

Last September, the U.S. House of representatives declared that September is Blood Cancer Awareness Month. In 2012 our focus was to help educate patients about the diseases and the resources available. [...]

CONTINUE READING

The Power of Patients (and an Increase in the Number of People With PV, ET, and MF)

Recently we shared the new prevalence data which put the number of people in the U.S. with PV, ET, and MF at nearly 300,000. That's a lot more people with MPN than we thought we were dealing with. [...]

CONTINUE READING
<< Previous  |  Next >>

About the Blog

Check back regularly for updates about what’s happening in the MPN community, from advocacy to research..

x

NEVER MISS AN UPDATE

Get free, timely information on living with an MPN.

Subscribe